Microbiome company Sequential Skin, has launched Sequential Bio, which it describes as “a novel in vivo microbiome testing solution uniquely tailored for companies across skincare, haircare and personal care product industries”. This is now on sale via the company website.
Sequential Bio, which is backed by multiple venture capital companies, has worked with over 25 personal care companies during the last 12 months to help them test and validate their own microbiome claims using in vivo tests. The firm has also developed highly sensitive assays that provides absolute quantification of the microbiome, which allows for higher resolution of key species and strain-level.
“Utilising the Sequential Bio solution allowed us to conduct tests in ‘real world’ conditions on consumers. This novel in vivo testing was pivotal for us as it validated our products as not just friendly, but also showed how beneficial it was for the skin microbiome,” commented Rob Calcraft, founder of Cultured Biomecare and former founder of Ren Skincare.
